Dr. Malcolm Moore (Memorial Sloan Kettering Cancer Center, New York, NY) is a prominent international cell biologist. He is one of the leading PhD investigators focusing on the characterization of normal and cancer stem cells, as well as the development of selective therapies. The Enid A. Haupt Chair of Cell Biology at the Memorial Sloan Kettering Cancer Center, Dr. Moore has made multiple discoveries throughout his career regarding cancer stem cells and blood formation. He played a key role in the invention of Neupogen, a drug used by millions of patients in cancer treatment, which stimulates the production of infection-fighting white blood cells. Throughout his notable career, Dr. Moore has received multiple awards and honors, including the Hope Funds Award of Excellence in Basic Research in Clinical Development.